Erratum: Retraction of 'Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats' (Diabetologia DOI: 10.1007/s00125-005-1766-7);Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats

Diabetologia

Volumn 48, Issue 6, 2005, Pages 1066-1074

  Hattori, Y ^a   Akimoto, K ^a   Gross, S S ^b   Hattori, S ^a   Kasai, K ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adiponectin; Angiotensin II; Metabolic syndrome; Oxidative stress; Tempol; Tetrahydrobiopterin

Indexed keywords

ADIPONECTIN; ANGIOTENSIN; HEPARIN COFACTOR; HYDROGEN PEROXIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN P22; PROTEIN P47; PROTEIN SUBUNIT; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCING AGENT; TEMPOL; TETRAHYDROBIOPTERIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG INFUSION; ENDOTHELIUM; ENZYME ACTIVITY; GENE EXPRESSION; HEART; HEART RATE; HYPERTENSION; MALE; MEASUREMENT; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORTHERN BLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE;

EID: 21344462138     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2159-8     Document Type: Erratum

References (43)

1. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
2. Ouchi N, Kihara S, Arita Y et al (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476
3. Hotta K, Funahashi T, Arita Y et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599
4. Kumada M, Kihara S, Sumitsuji S et al (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89
5. Ouchi N, Kihara S, Arita Y et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301
6. Ouchi N, Kihara S, Arita Y et al (2001) Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103:1057-1063
7. Arita Y, Kihara S, Ouchi N et al (2002) Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105:2893-2898
8. Matsuda M, Shimomura I, Sata M et al (2002) Role of adiponectin in preventing vascular stenosis: the missing link of adipovascular axis. J Biol Chem 277:37487-37491
9. Okamoto Y, Kihara S, Ouchi N et al (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770
10. Kubota N, Terauchi Y, Yamauchi T et al (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-26866
11. Suwaidi JA, Hamasaki S, Higano ST et al (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948-954
12. Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906
13. Hattori Y, Suzuki M, Hattori S, Kasai K (2003) Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia. 46:1543-1549
14. Shimabukuro M, Higa N, Asahi T et al (2003) Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88:3236-3240
15. Tan KC, Xu A, Chow WS et al (2004) Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89:765-769
16. Laursen JB, Rajagopalan S, Galis Z (1997) Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95:588-593
17. Wolf G (2000) Free radical production and angiotensin. Curr Hypertens Rep 2:167-173
18. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501
19. Ogihara T, Asano T, Ando K et al (2002) Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40:872-879
20. Hansson L, Lindholm LH, Niskanen L et al (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial. Lancet 353:611-616
21. Yusuf S, Gerstein H, Hoogwerf B et al (2001) Ramipril and the development of diabetes. JAMA 286:1882-1885
22. Dahlof B, Devereux RB, Kjeldsen SE (2002) Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995-1003
23. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM (2002) Mature adipocytes inhibit in vitro differentiation of human pre-adipocytes via angiotensin-type 1 receptors. Diabetes 51:1699-1707
24. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM (2002) Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 20:965-973
25. Schnackenberg CG, Wilcox CS (1999) Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin F2alpha. Hypertension 33:424-428
26. Schnackenberg CG, Wilcox CS (2001) The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 59:1859-1864
27. Hong HJ, Hsiao G, Cheng TH, Yen MH (2001) Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 38: 1044-1048
28. Vasquez-Vivar J, Kalyanaraman B, Martasek P et al (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95:9220-9225
29. Higashi M, Shimokawa H, Hattori T et al (2003) Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 93:767-775
30. Mukai Y, Shimokawa H, Higashi M et al (2002) Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler Thromb Vasc Biol 22:1445-1450
31. Kashiwagi A, Shinozaki K, Nishio Y et al (1999) Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol 277:E976-E983
32. Hattori Y, Kasai K, Gross SS (2004) NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc Res 63:31-40
33. Hattori Y, Gross SS (1993) GTP cyclohydrolase I mRNA is induced by LPS in vascular smooth muscle: characterization, sequence and relationship to nitric oxide synthase. Biochem Biophys Res Commun 195:435-441
34. Lassegue B, Sorescu D, Szocs K et al (2001) Novel gp91phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-894
35. Tirosh A, Potashnik R, Bashan N, Rudich A (1999) Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274: 10595-10602
36. Shimokawa H (1999) Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 31:23-37
37. Rajagopalan S, Kurz S, Munzel T et al (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923
38. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148
39. Pagano PJ, Clark JK, Cifuentes-Pagano ME (1997) Localization of constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 94:14483-14488
40. Fukui R, Ishizaka N, Rajagopalan S et al (1997) p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80:45-51
41. Furuhashi M, Ura N, Higashiura K et al (2003) Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42:76-81
42. Agata J, Nagahara D, Kinoshita S et al (2004) Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J 68:1194-1198
43. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290:1084-1089